Trial Profile

Clinical study of EPZ 5676 in patients with acute myeloid leukaemia with MLL-PTD genetic alterations

Status: Recruiting

Phase of Trial: Phase I

Latest Information Update: 06 Jul 2015

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Pinometostat (Primary)
Indications Acute myeloid leukaemia
Focus Adverse reactions; Therapeutic Use
Sponsors Epizyme

Most Recent Events

07 May 2014 This trial is recruiting patients into the expansion part of the trial. Data are expected to be reported in the second half of 2014, according to an Epizyme media release.
06 Nov 2013 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com